CN111150060A - Calcium-supplementing and blood-fat-reducing peony seed oil gel oral liquid and preparation method thereof - Google Patents
Calcium-supplementing and blood-fat-reducing peony seed oil gel oral liquid and preparation method thereof Download PDFInfo
- Publication number
- CN111150060A CN111150060A CN202010244513.2A CN202010244513A CN111150060A CN 111150060 A CN111150060 A CN 111150060A CN 202010244513 A CN202010244513 A CN 202010244513A CN 111150060 A CN111150060 A CN 111150060A
- Authority
- CN
- China
- Prior art keywords
- parts
- calcium
- seed oil
- peony seed
- oral liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000736199 Paeonia Species 0.000 title claims abstract description 63
- 235000006484 Paeonia officinalis Nutrition 0.000 title claims abstract description 63
- 235000015112 vegetable and seed oil Nutrition 0.000 title claims abstract description 57
- 239000007788 liquid Substances 0.000 title claims abstract description 40
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 74
- 102000008186 Collagen Human genes 0.000 claims abstract description 60
- 108010035532 Collagen Proteins 0.000 claims abstract description 60
- 108010038807 Oligopeptides Proteins 0.000 claims abstract description 60
- 102000015636 Oligopeptides Human genes 0.000 claims abstract description 60
- 229920001436 collagen Polymers 0.000 claims abstract description 60
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 51
- 239000011575 calcium Substances 0.000 claims abstract description 48
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 48
- BGNXCDMCOKJUMV-UHFFFAOYSA-N Tert-Butylhydroquinone Chemical compound CC(C)(C)C1=CC(O)=CC=C1O BGNXCDMCOKJUMV-UHFFFAOYSA-N 0.000 claims abstract description 34
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims abstract description 32
- 241000234314 Zingiber Species 0.000 claims abstract description 31
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 31
- 235000008397 ginger Nutrition 0.000 claims abstract description 31
- 239000008280 blood Substances 0.000 claims abstract description 20
- 210000004369 blood Anatomy 0.000 claims abstract description 20
- 239000004386 Erythritol Substances 0.000 claims abstract description 19
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims abstract description 19
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims abstract description 19
- 235000019414 erythritol Nutrition 0.000 claims abstract description 19
- 229940009714 erythritol Drugs 0.000 claims abstract description 19
- 230000001502 supplementing effect Effects 0.000 claims abstract description 19
- 229930003316 Vitamin D Natural products 0.000 claims abstract description 18
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims abstract description 18
- 235000019166 vitamin D Nutrition 0.000 claims abstract description 18
- 239000011710 vitamin D Substances 0.000 claims abstract description 18
- 150000003710 vitamin D derivatives Chemical class 0.000 claims abstract description 18
- 229940046008 vitamin d Drugs 0.000 claims abstract description 18
- 239000004250 tert-Butylhydroquinone Substances 0.000 claims abstract description 17
- 235000019281 tert-butylhydroquinone Nutrition 0.000 claims abstract description 17
- 239000002994 raw material Substances 0.000 claims abstract description 16
- YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 claims abstract description 12
- SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000000047 product Substances 0.000 claims abstract description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 33
- 238000010438 heat treatment Methods 0.000 claims description 32
- 239000000843 powder Substances 0.000 claims description 28
- 239000000243 solution Substances 0.000 claims description 22
- 238000002156 mixing Methods 0.000 claims description 20
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 17
- 239000001110 calcium chloride Substances 0.000 claims description 17
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 17
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 13
- 108010010779 glutamine-pyruvate aminotransferase Proteins 0.000 claims description 11
- 239000000839 emulsion Substances 0.000 claims description 10
- 239000011259 mixed solution Substances 0.000 claims description 10
- 239000007787 solid Substances 0.000 claims description 10
- 238000003756 stirring Methods 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 9
- 102000004190 Enzymes Human genes 0.000 claims description 6
- 108090000790 Enzymes Proteins 0.000 claims description 6
- 229940088598 enzyme Drugs 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 229920001661 Chitosan Polymers 0.000 claims description 5
- 239000004677 Nylon Substances 0.000 claims description 5
- 230000009920 chelation Effects 0.000 claims description 5
- 238000006243 chemical reaction Methods 0.000 claims description 5
- 238000005352 clarification Methods 0.000 claims description 5
- 238000001816 cooling Methods 0.000 claims description 5
- 238000005520 cutting process Methods 0.000 claims description 5
- 238000011049 filling Methods 0.000 claims description 5
- 229920001778 nylon Polymers 0.000 claims description 5
- 238000004806 packaging method and process Methods 0.000 claims description 5
- 238000004537 pulping Methods 0.000 claims description 5
- 238000001694 spray drying Methods 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 4
- 239000006228 supernatant Substances 0.000 claims description 4
- 108091005658 Basic proteases Proteins 0.000 claims description 2
- 108090000526 Papain Proteins 0.000 claims description 2
- 239000004365 Protease Substances 0.000 claims description 2
- 230000003301 hydrolyzing effect Effects 0.000 claims description 2
- 229940055729 papain Drugs 0.000 claims description 2
- 235000019834 papain Nutrition 0.000 claims description 2
- 208000001132 Osteoporosis Diseases 0.000 abstract description 6
- 230000036039 immunity Effects 0.000 abstract description 5
- 239000000796 flavoring agent Substances 0.000 abstract description 4
- 235000019634 flavors Nutrition 0.000 abstract description 4
- 230000006872 improvement Effects 0.000 abstract description 4
- 230000036541 health Effects 0.000 abstract description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 229940023492 oral liquid product Drugs 0.000 abstract 1
- 235000019197 fats Nutrition 0.000 description 11
- 230000000694 effects Effects 0.000 description 7
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- UILPJVPSNHJFIK-UHFFFAOYSA-N Paeonol Chemical compound COC1=CC=C(C(C)=O)C(O)=C1 UILPJVPSNHJFIK-UHFFFAOYSA-N 0.000 description 4
- 229930182558 Sterol Natural products 0.000 description 4
- 235000003702 sterols Nutrition 0.000 description 4
- 230000032683 aging Effects 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 208000029078 coronary artery disease Diseases 0.000 description 3
- 229940075507 glyceryl monostearate Drugs 0.000 description 3
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 150000003432 sterols Chemical class 0.000 description 3
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 3
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 3
- 241000251468 Actinopterygii Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 229940069978 calcium supplement Drugs 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- YLTGFGDODHXMFB-UHFFFAOYSA-N isoacetovanillon Natural products COC1=CC=C(C(C)=O)C=C1O YLTGFGDODHXMFB-UHFFFAOYSA-N 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- MLIBGOFSXXWRIY-UHFFFAOYSA-N paeonol Natural products COC1=CC=C(O)C(C(C)=O)=C1 MLIBGOFSXXWRIY-UHFFFAOYSA-N 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 description 1
- 206010006956 Calcium deficiency Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 208000032928 Dyslipidaemia Diseases 0.000 description 1
- 108010028554 LDL Cholesterol Proteins 0.000 description 1
- 208000017170 Lipid metabolism disease Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 206010047141 Vasodilatation Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 208000026758 coronary atherosclerosis Diseases 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000000110 microvilli Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- -1 sterol compounds Chemical class 0.000 description 1
- 150000001629 stilbenes Chemical class 0.000 description 1
- 235000021286 stilbenes Nutrition 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
- A23L33/165—Complexes or chelates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Botany (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The invention discloses a peony seed oil gel oral liquid for supplementing calcium and reducing blood fat and a preparation method thereof, and relates to the technical field of health care products. The oral liquid comprises the following raw materials in parts by weight: 10-30 parts of marine collagen oligopeptide calcium chelate, 10-30 parts of peony seed oil, 500 parts of red date, 40-80 parts of ginger, 0.001-0.002 part of vitamin D, 0.001-0.005 part of TBHQ, 0.001-0.004 part of citric acid, 20-35 parts of erythritol and 1-3 parts of glycerol monostearate. The health-care oral liquid takes the marine collagen oligopeptide calcium chelate and the peony seed oil as main raw materials, and red date, ginger, erythritol and the like are added for taste improvement, so that a convenient and reasonable production process is designed, the health-care oral liquid product has the functions of supplementing calcium, reducing blood fat, improving immunity of people, improving osteoporosis and the like, has good taste and moderate flavor, and is suitable for middle-aged and elderly people to take.
Description
Technical Field
The invention belongs to the technical field of health care products, and particularly relates to a peony seed oil gel oral liquid for supplementing calcium and reducing blood fat and a preparation method thereof.
Background
With the increasing aging degree of the population, the situation that the old people suffer from various chronic diseases at the same time becomes more and more serious, for the old people, dyslipidemia, especially the rise of triglyceride and low-density lipoprotein cholesterol, is one of the main risk factors for inducing coronary heart disease, and the calcium deficiency easily causes osteoporosis of the old people, causes the dangerous situations of fracture and the like, and seriously threatens the health of the old people.
The peony seed oil is pure natural green edible oil, contains various extremely important bioactive substances such as unique peony saponin, paeonol, peony polysaccharide, alpha-linolenic acid, peony sterol and the like, also contains various unsaturated fatty acids, various essential amino acids and various vitamin mineral substances, and is common oral liquid, but the existing peony seed oil oral liquid has poor taste and single function and does not have the function of calcium supplement, so that an oral liquid health-care product which has the functions of calcium supplement, blood fat reduction, immunity improvement, osteoporosis improvement, good taste and moderate flavor and is suitable for middle-aged and elderly people to take is designed, and meanwhile, the process is simple and fast, the industrial production can be quickly met, and the actual needs in the market at present are met.
Disclosure of Invention
The invention aims to provide a peony seed oil gel oral liquid for supplementing calcium and reducing blood fat and a preparation method thereof, wherein a marine collagen oligopeptide calcium chelate and peony seed oil are used as main raw materials, red date, ginger, erythritol and the like are added for taste improvement, a convenient and reasonable production process is designed, an oral liquid health-care product which has the advantages of supplementing calcium, reducing blood fat, improving immunity of people, improving osteoporosis, good taste and moderate flavor and is suitable for middle-aged and elderly people is developed, and the problems that the existing peony seed oil gel oral liquid has poor taste and single function and nutrient substances in the peony seed oil are difficult to fully absorb are solved.
In order to solve the technical problems, the invention is realized by the following technical scheme:
the invention relates to a peony seed oil gel oral liquid for supplementing calcium and reducing blood fat, which comprises the following raw materials in parts by weight: 10-30 parts of marine collagen oligopeptide calcium chelate, 10-30 parts of peony seed oil, 500 parts of red date, 40-80 parts of ginger, 0.001-0.002 part of vitamin D, 0.001-0.005 part of TBHQ, 0.001-0.004 part of citric acid, 20-35 parts of erythritol and 1-3 parts of glycerol monostearate.
Further, the oral liquid comprises the following raw materials in parts by weight: 18 parts of marine collagen oligopeptide calcium chelate, 15 parts of peony seed oil, 200 parts of red date, 50 parts of ginger, 0.001 part of vitamin D, 0.002 part of TBHQ, 0.002 part of citric acid, 20 parts of erythritol and 1 part of glycerol monostearate.
Further, the oral liquid comprises the following raw materials in parts by weight: 20 parts of marine collagen oligopeptide calcium chelate, 20 parts of peony seed oil, 300 parts of red date, 50 parts of ginger, 0.001 part of vitamin D, 0.004 part of TBHQ, 0.002 part of citric acid, 30 parts of erythritol and 1 part of glycerol monostearate.
Further, the oral liquid comprises the following raw materials in parts by weight: 30 parts of marine collagen oligopeptide calcium chelate, 30 parts of peony seed oil, 500 parts of red date, 80 parts of ginger, 0.002 part of vitamin D, 0.004 part of TBHQ, 0.003 part of citric acid, 35 parts of erythritol and 3 parts of glycerol monostearate.
The invention also provides a preparation method of the calcium-supplementing blood-fat-reducing peony seed oil oral liquid, which comprises the following steps:
the method comprises the following steps: dissolving the marine collagen oligopeptide powder in water, adding calcium chloride for chelation, wherein the ratio of the calcium chloride to the marine collagen oligopeptide powder is 1: (3-5), heating in water bath at 45-55 ℃ for 30-90min, and finally adjusting the pH value to 6.0-8.0 to obtain a marine collagen oligopeptide calcium solution;
step two: adding 5U/g glutamine transaminase into the marine collagen oligopeptide calcium solution obtained in the step one, uniformly mixing, heating in a water bath at 37 ℃ for 2-4h, heating at 85 ℃ to inactivate enzyme for 15min after the reaction is finished, cooling to room temperature, and performing spray drying to obtain marine collagen oligopeptide calcium chelate solid powder;
step three: removing cores of 100 plus materials of 500 parts of red dates, peeling 40-80 parts of ginger, cutting into blocks, adding 3 times of water for pulping, mixing and uniformly stirring after passing through 400-mesh nylon filter bags respectively, then adding chitosan for clarification treatment, taking supernatant, adding 20-35 parts of erythritol and 0.001-0.004 part of citric acid, uniformly mixing, and adjusting the pH value to 7.0;
step four: dissolving 10-30 parts of the marine collagen oligopeptide calcium chelate solid powder obtained in the step two in the solution obtained in the step three, and adjusting the pH value to 7.0 to obtain a red date ginger peptide calcium mixed solution;
step five: taking 10-30 parts of peony seed oil, mixing 0.001-0.005 part of TBHQ, 0.001-0.002 part of vitamin D and 1-3 parts of glycerin monostearate, keeping the temperature at 70 ℃, heating for 1 hour, slowly adding the mixture into the red date ginger peptide calcium mixed solution obtained in the fourth step, and stirring and homogenizing to obtain an emulsion;
step six: and (5) filling the emulsion obtained in the step five into a tube-shaped oral liquid bottle of 10ml in a vacuum sterile manner, and packaging to obtain a finished product.
Further, in the step one, the marine collagen oligopeptide powder is prepared by hydrolyzing deep sea fishbone or fishskin by using alkaline protease and papain.
Further, the ratio of the calcium chloride to the marine collagen oligopeptide powder in the first step can be specifically set to be 1: 3, the heating temperature of the water bath is set to be 50 ℃, the time is set to be 60min, the pH value is set to be 7.0, and the heating time of the marine collagen oligopeptide calcium solution and the glutamine transaminase in the water bath at 37 ℃ in the second step can be specifically set to be 2 h.
Further, the ratio of the calcium chloride to the marine collagen oligopeptide powder in the first step can be specifically set to be 1: and 4, setting the water bath heating temperature to be 45 ℃, the time to be 30min and the pH value to be 6.0, wherein the heating time of the marine collagen oligopeptide calcium solution and the glutamine transaminase in the water bath at 37 ℃ in the second step can be specifically set to be 3 h.
Further, the ratio of the calcium chloride to the marine collagen oligopeptide powder in the first step can be specifically set to be 1: and 5, setting the water bath heating temperature to be 55 ℃, the time to be 90min and the pH value to be 8.0, wherein the heating time of the marine collagen oligopeptide calcium solution and the glutamine transaminase in the water bath at 37 ℃ in the second step can be specifically set to be 4 h.
The invention has the following beneficial effects:
1. the invention contains the marine collagen oligopeptide calcium chelate and the vitamin D, has good calcium supplementing and calcium absorption promoting effects, and can improve the symptoms of osteoporosis, tooth loosening and the like after long-term administration.
2. The peony seed oil contains the peony seed oil, and because the peony seed oil contains unsaturated fatty acid with a high proportion and a certain amount of sterol compounds, the oral liquid has the effects of reducing blood pressure and blood fat and the like, can prevent diseases such as diabetes, coronary heart disease, atherosclerosis and the like after being taken for a long time, and simultaneously promotes cholesterol degradation and metabolism.
3. The peony seed oil has an anti-oxidation effect, and because the peony seed oil also contains various extremely important natural bioactive components such as unique peony saponin, paeonol, peony polysaccharide, peony sterol and the like, the peony seed oil has the effects of reducing the content of free radicals in a human body, intelligently adjusting the level of hormones in the human body, realizing the effects of resisting oxidation and aging and enhancing the vitality of the human body, and is the most natural young state substance energy, so the oral liquid has a certain effect of removing the oxidative free radicals in the human body after being taken for a long time, and has the effects of maintaining beauty, keeping young, resisting aging, improving immunity and the like after being taken for a.
4. The invention adjusts the taste by adding the red dates, the ginger and other ingredients, has good flavor, effectively removes the peculiar smell of the product in the deep sea fish processing process, and meets the market demand.
Of course, it is not necessary for any product in which the invention is practiced to achieve all of the above-described advantages at the same time.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Example 1
The invention relates to a peony seed oil gel oral liquid for supplementing calcium and reducing blood fat, which comprises the following raw materials in parts by weight: 18 parts of marine collagen oligopeptide calcium chelate, 15 parts of peony seed oil, 200 parts of red date, 50 parts of ginger, 0.001 part of vitamin D, 0.002 part of TBHQ, 0.002 part of citric acid, 20 parts of erythritol and 1 part of glycerol monostearate.
The invention also provides a preparation method of the calcium-supplementing blood-fat-reducing peony seed oil oral liquid, which comprises the following steps:
the method comprises the following steps: dissolving the marine collagen oligopeptide powder in water, adding calcium chloride for chelation, wherein the ratio of the calcium chloride to the marine collagen oligopeptide powder is 1: 3, heating in water bath at 50 ℃ for 60min, and finally adjusting the pH value to 7.0 to obtain a marine collagen oligopeptide calcium solution;
step two: adding 5U/g glutamine transaminase into the marine collagen oligopeptide calcium solution obtained in the step one, uniformly mixing, heating in a water bath at 37 ℃ for 2h, heating at 85 ℃ to inactivate enzyme for 15min after the reaction is finished, cooling to room temperature, and performing spray drying to obtain marine collagen oligopeptide calcium chelate solid powder;
step three: removing cores of 200 parts of red dates, peeling 50 parts of ginger, cutting into pieces, adding 3 times of water for pulping, respectively passing through a 400-mesh nylon filter bag, mixing and stirring uniformly, then adding chitosan for clarification, taking supernate, adding 20 parts of erythritol and 0.002 part of citric acid, mixing uniformly, and adjusting the pH value to 7.0;
step four: dissolving 18 parts of the marine collagen oligopeptide calcium chelate solid powder obtained in the step two in the solution obtained in the step three, and adjusting the pH value to 7.0 to obtain a red date ginger peptide calcium mixed solution;
step five: taking 15 parts of peony seed oil, mixing 0.002 part of TBHQ, 0.001 part of vitamin D and 1 part of glyceryl monostearate, keeping the temperature at 70 ℃, heating for 1 hour, slowly adding the mixture into the red date ginger peptide calcium mixed solution obtained in the fourth step, and stirring and homogenizing to obtain an emulsion;
step six: and (5) filling the emulsion obtained in the step five into a tube-shaped oral liquid bottle of 10ml in a vacuum sterile manner, and packaging to obtain a finished product.
Example 2
The invention relates to a peony seed oil gel oral liquid for supplementing calcium and reducing blood fat, which comprises the following raw materials in parts by weight: 20 parts of marine collagen oligopeptide calcium chelate, 20 parts of peony seed oil, 300 parts of red date, 50 parts of ginger, 0.001 part of vitamin D, 0.004 part of TBHQ, 0.002 part of citric acid, 30 parts of erythritol and 1 part of glycerol monostearate.
The invention also provides a preparation method of the calcium-supplementing blood-fat-reducing peony seed oil oral liquid, which comprises the following steps:
the method comprises the following steps: dissolving the marine collagen oligopeptide powder in water, adding calcium chloride for chelation, wherein the ratio of the calcium chloride to the marine collagen oligopeptide powder is 1: 4, heating in water bath at 45 ℃ for 30min, and finally adjusting the pH value to 6.0 to obtain a marine collagen oligopeptide calcium solution;
step two: adding 5U/g glutamine transaminase into the marine collagen oligopeptide calcium solution obtained in the step one, uniformly mixing, heating in a water bath at 37 ℃ for 3h, heating at 85 ℃ to inactivate enzyme for 15min after the reaction is finished, cooling to room temperature, and performing spray drying to obtain marine collagen oligopeptide calcium chelate solid powder;
step three: removing cores of 300 parts of red dates, peeling 50 parts of ginger, cutting into pieces, adding 3 times of water for pulping, respectively passing through a 400-mesh nylon filter bag, mixing and stirring uniformly, then adding chitosan for clarification, taking supernatant, adding 30 parts of erythritol and 0.002 part of citric acid, mixing uniformly, and adjusting the pH value to 7.0;
step four: dissolving 20 parts of the marine collagen oligopeptide calcium chelate solid powder obtained in the step two in the solution obtained in the step three, and adjusting the pH value to 7.0 to obtain a red date ginger peptide calcium mixed solution;
step five: taking 20 parts of peony seed oil, mixing 0.004 part of TBHQ, 0.001 part of vitamin D and 1 part of glyceryl monostearate, keeping the temperature at 70 ℃, heating for 1 hour, slowly adding the mixture into the red date ginger peptide calcium mixed solution obtained in the fourth step, and stirring and homogenizing to obtain an emulsion;
step six: and (5) filling the emulsion obtained in the step five into a tube-shaped oral liquid bottle of 10ml in a vacuum sterile manner, and packaging to obtain a finished product.
Example 3
The invention relates to a peony seed oil gel oral liquid for supplementing calcium and reducing blood fat, which comprises the following raw materials in parts by weight: 30 parts of marine collagen oligopeptide calcium chelate, 30 parts of peony seed oil, 500 parts of red date, 80 parts of ginger, 0.002 part of vitamin D, 0.004 part of TBHQ, 0.003 part of citric acid, 35 parts of erythritol and 3 parts of glycerol monostearate.
The invention also provides a preparation method of the calcium-supplementing blood-fat-reducing peony seed oil oral liquid, which comprises the following steps:
the method comprises the following steps: dissolving the marine collagen oligopeptide powder in water, adding calcium chloride for chelation, wherein the ratio of the calcium chloride to the marine collagen oligopeptide powder is 1: 5, heating in water bath at 55 ℃ for 90min, and finally adjusting the pH value to 8.0 to obtain a marine collagen oligopeptide calcium solution;
step two: adding 5U/g glutamine transaminase into the marine collagen oligopeptide calcium solution obtained in the step one, uniformly mixing, heating in a water bath at 37 ℃ for 4h, heating at 85 ℃ to inactivate enzyme for 15min after the reaction is finished, cooling to room temperature, and performing spray drying to obtain marine collagen oligopeptide calcium chelate solid powder;
step three: removing cores of 500 parts of red dates, peeling 80 parts of ginger, cutting into pieces, adding 3 times of water for pulping, respectively passing through a 400-mesh nylon filter bag, mixing and stirring uniformly, then adding chitosan for clarification, taking supernatant, adding 35 parts of erythritol and 0.003 part of citric acid, mixing uniformly, and adjusting the pH value to 7.0;
step four: dissolving 30 parts of the marine collagen oligopeptide calcium chelate solid powder obtained in the step two in the solution obtained in the step three, and adjusting the pH value to 7.0 to obtain a red date ginger peptide calcium mixed solution;
step five: taking 30 parts of peony seed oil, mixing 0.004 part of TBHQ, 0.002 part of vitamin D and 3 parts of glyceryl monostearate, keeping the temperature at 70 ℃, heating for 1 hour, slowly adding the mixture into the red date ginger peptide calcium mixed solution obtained in the fourth step, and stirring and homogenizing to obtain an emulsion;
step six: and (5) filling the emulsion obtained in the step five into a tube-shaped oral liquid bottle of 10ml in a vacuum sterile manner, and packaging to obtain a finished product.
The ocean collagen oligopeptide calcium chelate is prepared by taking fishbone and fishskin of deep-sea fish as main raw materials and adding calcium chloride into a small peptide mixture prepared by enzymolysis, separation, purification and the like, has various physiological activities such as antioxidation, blood pressure reduction, cholesterol reduction, vasodilatation promotion and the like, can be used as a raw material of a functional food additive, can overcome the defect of ionized calcium by active ingredients, is chelated into amino acid or peptide chelate by amino acid and small peptide secreted by brush borders of small intestine and Ca2+, and is absorbed by small intestine and enters human body to promote the absorption of calcium by human body, the chemical ingredients of peony seed oil mainly comprise water, fat, protein, starch, cellulose, pectin and inorganic salt, and in addition, terpenes, stilbenes, flavonoids, sterols, aldehydes, phenols and organic acid substances, more than 90 percent of fatty acid in the peony seed oil is unsaturated fatty acid, in addition, the peony seed oil also contains a small amount of stearic acid, the removal rate of DPPH free radicals and hydroxyl free radicals in the peony seed oil is higher than that of olive oil, the content of oxidizing enzyme in an organism can be effectively improved, and the peony seed oil also has a remarkable effect of reducing the content of total cholesterol in serum, so that the peony seed oil has the functions of supplementing calcium, reducing blood fat, improving immunity, improving osteoporosis and the like, and the oral liquid is better in taste due to the addition of red dates, ginger and other components, and is particularly suitable for middle-aged and elderly people to take.
In the description herein, references to the description of "one embodiment," "an example," "a specific example" or the like are intended to mean that a particular feature, structure, material, or characteristic described in connection with the embodiment or example is included in at least one embodiment or example of the invention. In this specification, the schematic representations of the terms used above do not necessarily refer to the same embodiment or example. Furthermore, the particular features, structures, materials, or characteristics described may be combined in any suitable manner in any one or more embodiments or examples.
The preferred embodiments of the invention disclosed above are intended to be illustrative only. The preferred embodiments are not intended to be exhaustive or to limit the invention to the precise embodiments disclosed. Obviously, many modifications and variations are possible in light of the above teaching. The embodiments were chosen and described in order to best explain the principles of the invention and the practical application, to thereby enable others skilled in the art to best utilize the invention. The invention is limited only by the claims and their full scope and equivalents.
Claims (9)
1. The peony seed oil gel oral liquid for supplementing calcium and reducing blood fat is characterized in that: the feed comprises the following raw materials in parts by weight: 10-30 parts of marine collagen oligopeptide calcium chelate, 10-30 parts of peony seed oil, 500 parts of red date, 40-80 parts of ginger, 0.001-0.002 part of vitamin D, 0.001-0.005 part of TBHQ, 0.001-0.004 part of citric acid, 20-35 parts of erythritol and 1-3 parts of glycerol monostearate.
2. The peony seed oil gel oral liquid for supplementing calcium and reducing blood fat according to claim 1, which is characterized by comprising the following raw materials in parts by weight: 18 parts of marine collagen oligopeptide calcium chelate, 15 parts of peony seed oil, 200 parts of red date, 50 parts of ginger, 0.001 part of vitamin D, 0.002 part of TBHQ, 0.002 part of citric acid, 20 parts of erythritol and 1 part of glycerol monostearate.
3. The peony seed oil gel oral liquid for supplementing calcium and reducing blood fat according to claim 1, which is characterized by comprising the following raw materials in parts by weight: 20 parts of marine collagen oligopeptide calcium chelate, 20 parts of peony seed oil, 300 parts of red date, 50 parts of ginger, 0.001 part of vitamin D, 0.004 part of TBHQ, 0.002 part of citric acid, 30 parts of erythritol and 1 part of glycerol monostearate.
4. The peony seed oil gel oral liquid for supplementing calcium and reducing blood fat according to claim 1, which is characterized by comprising the following raw materials in parts by weight: 30 parts of marine collagen oligopeptide calcium chelate, 30 parts of peony seed oil, 500 parts of red date, 80 parts of ginger, 0.002 part of vitamin D, 0.004 part of TBHQ, 0.003 part of citric acid, 35 parts of erythritol and 3 parts of glycerol monostearate.
5. The preparation method of the calcium-supplementing and blood-fat-reducing peony seed oil oral liquid based on any one of the above claims 1-4, which is characterized by comprising the following steps: the method comprises the following steps:
the method comprises the following steps: dissolving the marine collagen oligopeptide powder in water, adding calcium chloride for chelation, wherein the ratio of the calcium chloride to the marine collagen oligopeptide powder is 1: (3-5), heating in water bath at 45-55 ℃ for 30-90min, and finally adjusting the pH value to 6.0-8.0 to obtain a marine collagen oligopeptide calcium solution;
step two: adding 5U/g glutamine transaminase into the marine collagen oligopeptide calcium solution obtained in the step one, uniformly mixing, heating in a water bath at 37 ℃ for 2-4h, heating at 85 ℃ to inactivate enzyme for 15min after the reaction is finished, cooling to room temperature, and performing spray drying to obtain marine collagen oligopeptide calcium chelate solid powder;
step three: removing cores of 100 plus materials of 500 parts of red dates, peeling 40-80 parts of ginger, cutting into blocks, adding 3 times of water for pulping, mixing and uniformly stirring after passing through 400-mesh nylon filter bags respectively, then adding chitosan for clarification treatment, taking supernatant, adding 20-35 parts of erythritol and 0.001-0.004 part of citric acid, uniformly mixing, and adjusting the pH value to 7.0;
step four: dissolving 10-30 parts of the marine collagen oligopeptide calcium chelate solid powder obtained in the step two in the solution obtained in the step three, and adjusting the pH value to 7.0 to obtain a red date ginger peptide calcium mixed solution;
step five: taking 10-30 parts of peony seed oil, mixing 0.001-0.005 part of TBHQ, 0.001-0.002 part of vitamin D and 1-3 parts of glycerin monostearate, keeping the temperature at 70 ℃, heating for 1 hour, slowly adding the mixture into the red date ginger peptide calcium mixed solution obtained in the fourth step, and stirring and homogenizing to obtain an emulsion;
step six: and (5) filling the emulsion obtained in the step five into a tube-shaped oral liquid bottle of 10ml in a vacuum sterile manner, and packaging to obtain a finished product.
6. The method for preparing a peony seed oil gel oral liquid for supplementing calcium and reducing blood fat according to claim 5, wherein the ocean collagen oligopeptide powder in the step one is prepared by hydrolyzing deep sea fishbone or fishskin with alkaline protease and papain.
7. The preparation method of the peony seed oil gel oral liquid for supplementing calcium and reducing blood fat according to claim 5, wherein the ratio of calcium chloride to marine collagen oligopeptide powder in the first step is specifically set to 1: 3, the heating temperature of the water bath is set to be 50 ℃, the time is set to be 60min, the pH value is set to be 7.0, and the heating time of the marine collagen oligopeptide calcium solution and the glutamine transaminase in the water bath at 37 ℃ in the second step can be specifically set to be 2 h.
8. The preparation method of the peony seed oil gel oral liquid for supplementing calcium and reducing blood fat according to claim 5, wherein the ratio of calcium chloride to marine collagen oligopeptide powder in the first step is specifically set to 1: and 4, setting the water bath heating temperature to be 45 ℃, the time to be 30min and the pH value to be 6.0, wherein the heating time of the marine collagen oligopeptide calcium solution and the glutamine transaminase in the water bath at 37 ℃ in the second step can be specifically set to be 3 h.
9. The preparation method of the peony seed oil gel oral liquid for supplementing calcium and reducing blood fat according to claim 5, wherein the ratio of calcium chloride to marine collagen oligopeptide powder in the first step is specifically set to 1: and 5, setting the water bath heating temperature to be 55 ℃, the time to be 90min and the pH value to be 8.0, wherein the heating time of the marine collagen oligopeptide calcium solution and the glutamine transaminase in the water bath at 37 ℃ in the second step can be specifically set to be 4 h.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010244513.2A CN111150060A (en) | 2020-03-31 | 2020-03-31 | Calcium-supplementing and blood-fat-reducing peony seed oil gel oral liquid and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010244513.2A CN111150060A (en) | 2020-03-31 | 2020-03-31 | Calcium-supplementing and blood-fat-reducing peony seed oil gel oral liquid and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111150060A true CN111150060A (en) | 2020-05-15 |
Family
ID=70567812
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010244513.2A Pending CN111150060A (en) | 2020-03-31 | 2020-03-31 | Calcium-supplementing and blood-fat-reducing peony seed oil gel oral liquid and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111150060A (en) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102160615A (en) * | 2011-02-24 | 2011-08-24 | 洛阳红娇天香牡丹生物有限公司 | Health-care food component taking peony extract as base material and application thereof |
| CN102871121A (en) * | 2012-10-10 | 2013-01-16 | 中国食品发酵工业研究院 | Preparation method of oceanic ossein peptide calcium chelate biological calcium supplement |
| CN102907741A (en) * | 2012-10-24 | 2013-02-06 | 刘文锋 | Preparation method of peony seed oil oral liquid |
| CN103960717A (en) * | 2014-04-09 | 2014-08-06 | 洛阳春魁农业开发有限公司 | Peony plant protein beverage and preparation method thereof |
| CN110876766A (en) * | 2019-12-07 | 2020-03-13 | 广东医科大学 | Application of peony seed oil in preparation of medicines and health-care foods for improving biomechanical properties of male bones |
-
2020
- 2020-03-31 CN CN202010244513.2A patent/CN111150060A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102160615A (en) * | 2011-02-24 | 2011-08-24 | 洛阳红娇天香牡丹生物有限公司 | Health-care food component taking peony extract as base material and application thereof |
| CN102871121A (en) * | 2012-10-10 | 2013-01-16 | 中国食品发酵工业研究院 | Preparation method of oceanic ossein peptide calcium chelate biological calcium supplement |
| CN102907741A (en) * | 2012-10-24 | 2013-02-06 | 刘文锋 | Preparation method of peony seed oil oral liquid |
| CN103960717A (en) * | 2014-04-09 | 2014-08-06 | 洛阳春魁农业开发有限公司 | Peony plant protein beverage and preparation method thereof |
| CN110876766A (en) * | 2019-12-07 | 2020-03-13 | 广东医科大学 | Application of peony seed oil in preparation of medicines and health-care foods for improving biomechanical properties of male bones |
Non-Patent Citations (1)
| Title |
|---|
| 代慧慧等: "牡丹籽油开发应用的研究进展", 《粮食与油脂》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103054113B (en) | Composite fruit-vegetable juice beverage with blood sugar decreasing effect | |
| KR20140103572A (en) | A functional liquid composition comprising arginine, maca powder extract, citric acid and polydextrose as main ingredients | |
| CN104054847A (en) | Health-improving, body-building and nourishing peanut oil and preparation method thereof | |
| CN106689948A (en) | Collagen composite linolenic acid beverage and preparation method thereof | |
| CN101785505B (en) | Black soya bean soymilk beverage and production method thereof | |
| CN101438841A (en) | Tomato juice health-care beverage | |
| CN107484984B (en) | Stichopus japonicus oral liquid rich in Stichopus japonicus active polysaccharide and its preparation method | |
| CN104513776A (en) | Preparation method of pitaya fruit vinegar | |
| CN103478295B (en) | Calcium-supplement and health-care grape seed oil | |
| CN102334633A (en) | Aloe nutrition noodles | |
| CN105851374A (en) | Lemon ginger tea and preparation method thereof | |
| CN103947769B (en) | A kind of have peanut oil of the pleasant function that helps digestion and preparation method thereof | |
| CN111150060A (en) | Calcium-supplementing and blood-fat-reducing peony seed oil gel oral liquid and preparation method thereof | |
| CN105795032A (en) | Green tea and ginger tea and preparation method thereof | |
| CN104059835A (en) | Pumpkin wine | |
| CN103937597A (en) | Heat clearing and detoxifying peanut oil and its preparation method | |
| CN105831343A (en) | Ginseng ginger tea and preparation method thereof | |
| CN105901218A (en) | Kudzu root ginger tea and preparation method of same | |
| CN107156805A (en) | A kind of health products and its manufacture method | |
| CN105901217A (en) | Red date ginger tea and preparation method thereof | |
| CN105901219A (en) | Dendrobe ginger tea and preparation method for same | |
| CN107279957B (en) | Ginkgo and shiitake mushroom sauce and preparation method thereof | |
| CN104523551A (en) | Chinese yam mask and preparation method thereof | |
| CN103931793A (en) | Face-nourishing appearance-beautifying peanut oil and preparation method thereof | |
| CN105851372A (en) | Brown sugar and ginger tea and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20200515 |
|
| WD01 | Invention patent application deemed withdrawn after publication |